Intranasal administration of insulin lowers amyloid- levels in rat model of diabetes.
Indian J Exp Biol
;
2012 Jan; 50(1): 41-44
Artículo
en Inglés
| IMSEAR
| ID: sea-145220
ABSTRACT
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by abnormal accumulation of amyloid (A) peptide in brain regions subserving memory and other cognitive functions. Hyperglycemia and perturbed insulin signaling have been proposed as pathogenic factors contributing to AD. The aim of the present study is to validate the use of streptozotocin (STZ) injected rats as an experimental model of AD. Using this model, the effect of intranasal administration of insulin on reduction of Aß levels was measured. The current findings strengthen the case for insulin as therapy for AD afflicted individuals with or without diabetes.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
Indian J Exp Biol
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS